FibroBiologics, Inc.
FBLG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001958777
No open-market purchases or sales by FibroBiologics, Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $269.6K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in FibroBiologics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- −6 vs. Q1 2025
- Shares held
- 5.96M
- −464.0K (−7.2%) vs. Q1 2025
- Total value
- $3.75M
- −$2.06M (−35.5%) vs. Q1 2025
- New holders
- 15
- 14 more added
- Sold out
- 21
- 16 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FBLG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $269.6K |
| Q1 2026 | 17 | $291.1K |
| Q4 2025 | 46 | $993.8K |
| Q3 2025 | 55 | $2.93M |
| Q2 2025 | 59 | $3.75M |
| Q1 2025 | 65 | $5.81M |
| Q4 2024 | 64 | $11.9M |
| Q3 2024 | 61 | $16.8M |
| Q2 2024 | 50 | $17.2M |
| Q1 2024 | 17 | $5.18M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding FibroBiologics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $1 | 0.00% | −29,711−100.0% | Reduced |
| IFP Advisors, Inc | 2 | $1 | 0.00% | +2 | New |
| Essential Partners LLC | 12 | $7 | 0.00% | +12 | New |
| Deutsche Bank AG | 18 | $11 | 0.00% | −2,584−99.3% | Reduced |
| EverSource Wealth Advisors, LLC | 122 | $76 | 0.00% | −32−20.8% | Reduced |
| Citigroup Inc | 171 | $106 | 0.00% | −19,309−99.1% | Reduced |
| True Wealth Design, LLC | 192 | $120 | 0.00% | +51+36.2% | Added |
| Clearstead Advisors, LLC | 202 | $126 | 0.00% | +202 | New |
| Allworth Financial LP | 261 | $163 | 0.00% | 00.0% | Unchanged |
| Islay Capital Management, LLC | 450 | $280 | 0.00% | +450 | New |
| Wells Fargo & Company | 725 | $451 | 0.00% | −12,541−94.5% | Reduced |
| Royal Bank of Canada | 1,896 | $1.00K | 0.00% | +735+63.3% | Added |
| BNP Paribas Arbitrage, SA | 1,718 | $1.07K | 0.00% | −676−28.2% | Reduced |
| Cubist Systematic Strategies, LLC | 1,844 | $1.15K | 0.00% | +1,844 | New |
| Grove Bank & Trust | 2,000 | $1.24K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 3,620 | $2.00K | 0.00% | +387+12.0% | Added |
| FMR LLC | 3,296 | $2.05K | 0.00% | −3,182−49.1% | Reduced |
| Morgan Stanley | 6,204 | $3.86K | 0.00% | −30,455−83.1% | Reduced |
| Advisor Group Holdings, Inc. | 8,000 | $4.96K | 0.00% | +2,500+45.5% | Added |
| Hantz Financial Services, Inc. | 8,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Skopos Labs, Inc. | 11,500 | $7.16K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 12,570 | $7.82K | 0.00% | +12,570 | New |
| Flaharty Asset Management, LLC | 14,702 | $9.15K | 0.00% | 00.0% | Unchanged |
| Cahaba Wealth Management, Inc. | 14,702 | $9.15K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 15,220 | $9.47K | 0.00% | +5,636+58.8% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 16,494 | $10.3K | 0.00% | +16,494 | New |
| Raymond James Financial Inc | 18,642 | $11.6K | 0.00% | 00.0% | Unchanged |
| Cetera Investment Advisers | 19,006 | $11.8K | 0.00% | +1,871+10.9% | Added |
| GWM Advisors LLC | 22,906 | $14.3K | 0.00% | 00.0% | Unchanged |
| Saxon Interests, Inc. | 21,214 | $19.1K | 0.01% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 34,092 | $21.2K | 0.00% | +34,092 | New |
| Concurrent Investment Advisors, LLC | 35,283 | $22.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 37,802 | $23.0K | 0.00% | +37,802 | New |
| RMR Wealth Builders | 38,360 | $23.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 40,000 | $24.9K | 0.00% | −35,000−46.7% | Reduced |
| XTX Topco Ltd | 45,945 | $28.6K | 0.00% | +28,276+160.0% | Added |
| Bank of America Corp | 47,750 | $29.7K | 0.00% | −44,289−48.1% | Reduced |
| Northern Trust Corp | 48,112 | $29.9K | 0.00% | −158,003−76.7% | Reduced |
| AQR Capital Management LLC | 52,217 | $32.5K | 0.00% | +19,990+62.0% | Added |
| Y-Intercept (Hong Kong) Ltd | 59,539 | $37.0K | 0.00% | +59,539 | New |
| Wiley Bros.-Aintree Capital, LLC | 70,000 | $43.6K | 0.00% | +70,000 | New |
| Marshall Wace, LLP | 78,618 | $48.7K | 0.00% | +78,618 | New |
| American Institute for Advanced Investment Management, LLP | 88,206 | $54.9K | 0.04% | 00.0% | Unchanged |
| Jane Street Group, LLC | 96,110 | $59.8K | 0.00% | +96,110 | New |
| Ethos Financial Group, LLC | 48,848 | $64.0K | 0.01% | +24,424+100.0% | Added |
| Susquehanna International Group, LLP | 106,100 | $66.0K | 0.00% | +70,897+201.4% | Added |
| Requisite Capital Management, LLC | 109,713 | $68.3K | 0.01% | 00.0% | Unchanged |
| Optivise Advisory Services LLC | 110,100 | $68.5K | 0.04% | 00.0% | Unchanged |
| UBS Group AG | 110,274 | $68.6K | 0.00% | −2,585−2.3% | Reduced |
| State Street Corp | 115,500 | $71.9K | 0.00% | −450,952−79.6% | Reduced |
| Cerity Partners LLC | 128,109 | $79.7K | 0.00% | +34,702+37.2% | Added |
| Goldman Sachs Group Inc | 131,542 | $81.8K | 0.00% | +62,916+91.7% | Added |
| Citadel Advisors LLC | 233,369 | $145.2K | 0.00% | +185,144+383.9% | Added |
| Geode Capital Management, LLC | 288,948 | $179.9K | 0.00% | −325,691−53.0% | Reduced |
| Cascade Financial Partners, LLC | 290,581 | $180.8K | 0.02% | +30,500+11.7% | Added |
| Millennium Management LLC | 480,645 | $299.1K | 0.00% | +480,645 | New |
| BlackRock, Inc. | 750,898 | $467.2K | 0.00% | −1,014,732−57.5% | Reduced |
| Yorkville Advisors Global, LP | 844,103 | $525.2K | 0.27% | +844,103 | New |
| Vanguard Group Inc | 1,233,781 | $767.4K | 0.00% | −186,638−13.1% | Reduced |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −69,805−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −51,420−100.0% | Sold out |
| Nuveen, LLC | 0 | $0 | 0.00% | −34,540−100.0% | Sold out |
| ERn Financial, LLC | 0 | $0 | 0.00% | −31,819−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −23,356−100.0% | Sold out |
| Intech Investment Management LLC | 0 | $0 | 0.00% | −22,002−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −20,524−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −19,367−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −16,627−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −13,396−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −12,659−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −12,318−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −4,700−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −4,103−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −2,900−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −2,816−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −2,493−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −2,153−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −880−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −196−100.0% | Sold out |
| Sterling Capital Management LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |